Human Herpes Simplex Virus: Life Cycle and Development of Inhibitors

被引：119
|
作者：
Kukhanova, M. K. [1 ]
Korovina, A. N. [1 ]
Kochetkov, S. N. [1 ]
机构：
[1] Russian Acad Sci, VA Engelhardt Mol Biol Inst, Moscow 119991, Russia
来源：
BIOCHEMISTRY-MOSCOW | 2014年 / 79卷 / 13期
基金：
俄罗斯基础研究基金会;
关键词：
HSV; herpes simplex; life cycle; replication; drugs; mutations; resistance; TYPE-1; DNA-POLYMERASE; HELICASE-PRIMASE INHIBITORS; NUCLEAR-LOCALIZATION SIGNAL; GUINEA-PIG MODEL; THYMIDINE KINASE; VIRAL REPLICATION; C-TERMINUS; IN-VITRO; HERPES-SIMPLEX-VIRUS-1; DNA; ANTIHERPESVIRUS ACTIVITY;
D O I：
10.1134/S0006297914130124
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
WHO reports that 90% of human population is infected by different types of herpesviruses, which develop latency or cause oral and genital herpes, conjunctivitis, eczema herpeticum, and other diseases. Herpesvirus almost always accompanies HIV-infection and complicates AIDS treatment. Herpes simplex virus type 1 is one of the most wide spread viruses from the Herpesviridae family. HSV virion, genome structure, replication mechanisms, antiherpes drug development strategies, including design of prodrugs, and mutations causing ACV-resistance in clinical HSV isolates are discussed in this review.
引用
收藏
页码：1635 / 1652
页数：18
相关论文
共 50 条
  • [21] RELATIONSHIP OF HERPES SIMPLEX HAEMADSORPTION PHENOMENON TO VIRUS GROWTH CYCLE
    WATKINS, JF
    VIROLOGY, 1965, 26 (04) : 746 - &
  • [22] Herpes simplex virus helicase-primase inhibitors are active in animal models of human disease
    James J. Crute
    Christine A. Grygon
    Karl D. Hargrave
    Bruno Simoneau
    Anne-Marie Faucher
    Gordon Bolger
    Philip Kibler
    Michel Liuzzi
    Michael G. Cordingley
    Nature Medicine, 2002, 8 : 386 - 391
  • [23] Herpes simplex virus helicase-primase inhibitors are active in animal models of human disease
    Crute, JJ
    Grygon, CA
    Hargrave, KD
    Simoneau, B
    Faucher, AM
    Bolger, G
    Kibler, P
    Liuzzi, M
    Cordingley, MG
    NATURE MEDICINE, 2002, 8 (04) : 386 - 391
  • [24] HERPES SIMPLEX VIRUS
    Frobert, E.
    Ducastelle-Lepretre, S.
    Casalegno, J.
    Nave, V.
    Eibach, D.
    Lina, B.
    Morfin, F.
    SEXUALLY TRANSMITTED INFECTIONS, 2013, 89 : A16 - A16
  • [25] Herpes simplex virus
    Riley, LE
    SEMINARS IN PERINATOLOGY, 1998, 22 (04) : 284 - 292
  • [26] Herpes simplex virus
    Waggoner-Fountain, LA
    Grossman, LB
    PEDIATRICS IN REVIEW, 2004, 25 (03) : 86 - 93
  • [27] Herpes simplex virus
    Taylor, TJ
    Brockman, MA
    McNamee, EE
    Knipe, DM
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2002, 7 : D752 - D764
  • [28] Flavonoids with Anti-Herpes Simplex Virus Properties: Deciphering Their Mechanisms in Disrupting the Viral Life Cycle
    Sudomova, Miroslava
    Hassan, Sherif T. S.
    VIRUSES-BASEL, 2023, 15 (12):
  • [29] Herpes simplex virus
    Klapper, PE
    Cleator, GM
    INTERVIROLOGY, 1997, 40 (2-3) : 62 - 71
  • [30] The Telomerase Inhibitor MST-312 Interferes with Multiple Steps in the Herpes Simplex Virus Life Cycle
    Haberichter, Jarod
    Roberts, Scott
    Abbasi, Imran
    Dedthanou, Phonphanh
    Pradhan, Prajakta
    Nguyen, Marie L.
    JOURNAL OF VIROLOGY, 2015, 89 (19) : 9804 - 9816
12345